Literature DB >> 10885765

Towards a better understanding of the epidemiology of HIV-2.

M F Schim van der Loeff1, P Aaby.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10885765

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  32 in total

1.  Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau.

Authors:  W P Schmidt; M Schim Van Der Loeff; P Aaby; H Whittle; R Bakker; M Buckner; F Dias; R G White
Journal:  Epidemiol Infect       Date:  2007-06-11       Impact factor: 2.451

Review 2.  Antiretroviral drug resistance in human immunodeficiency virus type 2.

Authors:  Michel L Ntemgwa; Thomas d'Aquin Toni; Bluma G Brenner; Ricardo J Camacho; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

3.  Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali.

Authors:  Josue Togo; Almoustapha Issiaka Maiga; Mariam Sylla; Bourahima Kone; Oumar Dolo; Fatoumata Tata Traore; Samba Adama Sangare; Mamoudou Maiga; Souleymane Diallo; Robert Murphy; Vincent Calvez; Anne-Genevieve Marcelin
Journal:  AIDS Res Hum Retroviruses       Date:  2019-01-22       Impact factor: 2.205

4.  Human Immunodeficiency Virus (HIV).

Authors: 
Journal:  Transfus Med Hemother       Date:  2016-05-09       Impact factor: 3.747

5.  Cloning, expression, and purification of HIV-2 gp125: A target for HIV vaccination.

Authors:  Samer Sourial; Anette Wärnmark; Charlotta Nilsson; Ewa Björling; Adnane Achour; Robert A Harris
Journal:  Mol Biotechnol       Date:  2005-06       Impact factor: 2.695

6.  Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat.

Authors:  Martine Peeters; Valerie Courgnaud; Bernadette Abela; Philippe Auzel; Xavier Pourrut; Frederic Bibollet-Ruche; Severin Loul; Florian Liegeois; Cristelle Butel; Denis Koulagna; Eitel Mpoudi-Ngole; George M Shaw; Beatrice H Hahn; Eric Delaporte
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

7.  Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance.

Authors:  Robert A Smith; Donovan J Anderson; Crystal L Pyrak; Bradley D Preston; Geoffrey S Gottlieb
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

8.  Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.

Authors:  Qin Lizeng; Charlotta Nilsson; Samer Sourial; Sören Andersson; Olav Larsen; Peter Aaby; Mariethe Ehnlund; Ewa Björling
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Authors:  Sabelle Jallow; Abraham Alabi; Ramu Sarge-Njie; Kevin Peterson; Hilton Whittle; Tumani Corrah; Assan Jaye; Matthew Cotten; Guido Vanham; Samuel J McConkey; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

10.  Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro.

Authors:  Robert A Smith; Geoffrey S Gottlieb; Donovan J Anderson; Crystal L Pyrak; Bradley D Preston
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.